Cochrane Abstracts
Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fluid Restriction for Treatment of Symptomatic Patent Ductus Arteriosus in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440704/all/Fluid_restriction_for_treatment_of_symptomatic_patent_ductus_arteriosus_in_preterm_infants.
Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440704/all/Fluid_restriction_for_treatment_of_symptomatic_patent_ductus_arteriosus_in_preterm_infants. Accessed March 16, 2025.
Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440704/all/Fluid_restriction_for_treatment_of_symptomatic_patent_ductus_arteriosus_in_preterm_infants
Fluid Restriction for Treatment of Symptomatic Patent Ductus Arteriosus in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440704/all/Fluid_restriction_for_treatment_of_symptomatic_patent_ductus_arteriosus_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants
ID - 440704
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440704/all/Fluid_restriction_for_treatment_of_symptomatic_patent_ductus_arteriosus_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
